Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 180

1.

Application of a Dual-Dispatch System for Out-of-Hospital Cardiac Arrest Patients: Will More Hands Save More Lives?

Kim JH, Ryoo HW, Kim JY, Ahn JY, Moon S, Lee DE, Mun YH.

J Korean Med Sci. 2019 Sep 2;34(34):e141. doi: 10.3346/jkms.2019.34.e141.

2.

Impact of depth of response on survival in patients treated with cobimetinib ± vemurafenib: pooled analysis of BRIM-2, BRIM-3, BRIM-7 and coBRIM.

Lewis KD, Larkin J, Ribas A, Flaherty KT, McArthur GA, Ascierto PA, Dréno B, Yan Y, Wongchenko M, McKenna E, Zhu Q, Mun Y, Hauschild A.

Br J Cancer. 2019 Aug 16. doi: 10.1038/s41416-019-0546-y. [Epub ahead of print]

PMID:
31417188
3.

Clinical Outcomes of Decitabine Treatment for Patients With Lower-Risk Myelodysplastic Syndrome on the Basis of the International Prognostic Scoring System.

Jung KS, Kim YJ, Kim YK, Park SK, Kim HG, Kim SJ, Park J, Choi CW, Do YR, Kim I, Park S, Mun YC, Jeong SH, Kim MK, Yi HG, Chang MH, Kim SY, Lee JH, Jang JH.

Clin Lymphoma Myeloma Leuk. 2019 Jun 27. pii: S2152-2650(19)30234-4. doi: 10.1016/j.clml.2019.06.003. [Epub ahead of print]

PMID:
31375393
4.

Clinical implication of renal dysfunction during the clinical course in patients with paroxysmal nocturnal hemoglobinuria: a longitudinal analysis.

Kim JS, Cheong JW, Mun YC, Jang JH, Jo DY, Lee JW; Aplastic Anemia Working Party of the Korean Society of Hematology.

Ann Hematol. 2019 Oct;98(10):2273-2281. doi: 10.1007/s00277-019-03735-6. Epub 2019 Jun 29.

PMID:
31256219
5.

Effect of concomitant dosing with acid-reducing agents and vemurafenib dose on survival in patients with BRAFV600 mutation-positive metastatic melanoma treated with vemurafenib ± cobimetinib.

Lewis K, Hauschild A, Larkin J, Ribas A, Flaherty KT, McArthur GA, Dréno B, McKenna E, Zhu Q, Mun Y, Ascierto PA.

Eur J Cancer. 2019 Jul;116:45-55. doi: 10.1016/j.ejca.2019.05.002. Epub 2019 Jun 4.

PMID:
31173962
6.

Prognostic risk score for patients with relapsed or refractory chronic lymphocytic leukaemia treated with targeted therapies or chemoimmunotherapy: a retrospective, pooled cohort study with external validations.

Soumerai JD, Ni A, Darif M, Londhe A, Xing G, Mun Y, Kay NE, Shanafelt TD, Rabe KG, Byrd JC, Chanan-Khan AA, Furman RR, Hillmen P, Jones J, Seymour JF, Sharman JP, Ferrante L, Mobasher M, Stark T, Reddy V, Dreiling LK, Bhargava P, Howes A, James DF, Zelenetz AD.

Lancet Haematol. 2019 Jul;6(7):e366-e374. doi: 10.1016/S2352-3026(19)30085-7. Epub 2019 May 17. Erratum in: Lancet Haematol. 2019 Jul;6(7):e348.

PMID:
31109827
7.

Versatile Strategy for Tuning ORR Activity of a Single Fe-N4 Site by Controlling Electron-Withdrawing/Donating Properties of a Carbon Plane.

Mun Y, Lee S, Kim K, Kim S, Lee S, Han JW, Lee J.

J Am Chem Soc. 2019 Apr 17;141(15):6254-6262. doi: 10.1021/jacs.8b13543. Epub 2019 Apr 5.

PMID:
30920818
8.

A Phase I/II, Open-Label, Prospective, Multicenter Study to Evaluate the Efficacy and Safety of Lower Doses of Bortezomib Plus Busulfan and Melphalan as a Conditioning Regimen in Patients with Multiple Myeloma Undergoing Autologous Peripheral Blood Stem Cell Transplantation: The KMM103 Study.

Park SS, Kim K, Kim SJ, Lee JH, Yoon SS, Mun YC, Lee JJ, Eom HS, Kim JS, Min CK; Korean Multiple Myeloma Working Party.

Biol Blood Marrow Transplant. 2019 Jul;25(7):1312-1319. doi: 10.1016/j.bbmt.2019.03.016. Epub 2019 Mar 23.

PMID:
30910603
9.

The Effect of Cognitive Intervention on Cognitive Improvement in Patients with Dementia.

Jo K, Jhoo JH, Mun YJ, Kim YM, Kim SK, Kim S, Lee SH, Jang JW.

Dement Neurocogn Disord. 2018 Mar;17(1):23-31. doi: 10.12779/dnd.2018.17.1.23. Epub 2018 Mar 14.

10.

Degranulated Eosinophils Contain More Fine Nerve Fibers in the Duodenal Mucosa of Patients With Functional Dyspepsia.

Lee MJ, Jung HK, Lee KE, Mun YC, Park S.

J Neurogastroenterol Motil. 2019 Apr 30;25(2):212-221. doi: 10.5056/jnm18176.

11.

Ten-year analysis of microbiological profile and antibiotic sensitivity for bacterial keratitis in Korea.

Mun Y, Kim MK, Oh JY.

PLoS One. 2019 Mar 1;14(3):e0213103. doi: 10.1371/journal.pone.0213103. eCollection 2019.

12.

Somatic mutation of HLA-DRB1*04:03 in a patient with myelodysplastic syndrome at diagnosis.

Park S, Jeong TD, Mun YC, Seo D, Im J, Huh J.

HLA. 2019 Apr;93(4):216-219. doi: 10.1111/tan.13490. Epub 2019 Mar 13.

PMID:
30773841
13.

Acute Cholecystitis in Elderly Patients after Hip Fracture: a Nationwide Cohort Study.

Jang SY, Cha YH, Mun YS, Kim SH, Kim HY, Choy WS.

J Korean Med Sci. 2019 Jan 25;34(5):e36. doi: 10.3346/jkms.2019.34.e36. eCollection 2019 Feb 4.

14.

[A Case of Curative Resection of Advanced Rectal Cancer with Multiple Liver Metastases and Cancerous Ascites after Preoperative Chemotherapy].

Mitsuhashi N, Shimizu Y, Mun Y, Yoneura N, Sakai N, Takano S, Kuboki S, Takayashiki T, Furukawa K, Yoshitomi H, Ohtsuka M.

Gan To Kagaku Ryoho. 2018 Dec;45(13):2193-2195. Japanese.

PMID:
30692328
15.

Post-traumatic pseudoaneurysms of the left gastric artery: A case report.

Noh D, Mun YS.

Trauma Case Rep. 2018 Dec 5;19:1-6. doi: 10.1016/j.tcr.2018.11.005. eCollection 2019 Feb.

16.

Reconfigurable Sensor Analog Front-End Using Low-Noise Chopper-Stabilized Delta-Sigma Capacitance-to-Digital Converter.

Kim H, Lee B, Mun Y, Kim J, Han K, Roh Y, Song D, Huh S, Ko H.

Micromachines (Basel). 2018 Jul 10;9(7). pii: E347. doi: 10.3390/mi9070347.

17.

The Derived Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Factor in Transplantation Ineligible Patients with Multiple Myeloma.

Lee GW, Park SW, Go SI, Kim HG, Kim MK, Min CK, Kwak JY, Bae SB, Yoon SS, Lee JJ, Kim KH, Nam SH, Mun YC, Kim HJ, Bae SH, Shin HJ, Lee JH, Park JS, Jeong SH, Lee MH, Lee HS, Park KW, Lee WS, Lee SM, Lee JO, Hyun MS, Jo DY, Lim SN, Lee JH, Kim H, Cho DY, Do YR, Kim JA, Park SK, Kim JS, Kim SJ, Yi HG, Moon JH, Choi CW, Kim SH, Kim BS, Park MR, Shim H, Song MK, Kim Y, Kim K.

Acta Haematol. 2018;140(3):146-156. doi: 10.1159/000490488. Epub 2018 Sep 25.

PMID:
30253397
18.

T cell microvilli constitute immunological synaptosomes that carry messages to antigen-presenting cells.

Kim HR, Mun Y, Lee KS, Park YJ, Park JS, Park JH, Jeon BN, Kim CH, Jun Y, Hyun YM, Kim M, Lee SM, Park CS, Im SH, Jun CD.

Nat Commun. 2018 Sep 7;9(1):3630. doi: 10.1038/s41467-018-06090-8.

19.

Therapeutic effects of 3% diquafosol ophthalmic solution in patients with short tear film break-up time-type dry eye disease.

Mun Y, Kwon JW, Oh JY.

BMC Ophthalmol. 2018 Sep 5;18(1):237. doi: 10.1186/s12886-018-0910-3.

20.

Modeled Prognostic Subgroups for Survival and Treatment Outcomes in BRAF V600-Mutated Metastatic Melanoma: Pooled Analysis of 4 Randomized Clinical Trials.

Hauschild A, Larkin J, Ribas A, Dréno B, Flaherty KT, Ascierto PA, Lewis KD, McKenna E, Zhu Q, Mun Y, McArthur GA.

JAMA Oncol. 2018 Oct 1;4(10):1382-1388. doi: 10.1001/jamaoncol.2018.2668.

21.

Sarcomatoid Adenocarcinoma of the Ampulla of Vater.

Jung JH, Mun YS.

Indian J Surg Oncol. 2018 Jun;9(2):274-277. doi: 10.1007/s13193-018-0743-9. Epub 2018 Apr 7.

22.

Factors Affecting Endoscopic Curative Resection of Gastric Cancer in the Population-Based Screening Era.

Mun YG, Choi MG, Lim CH, Lee HH, Kang DH, Park JM, Song KY.

Clin Endosc. 2018 Sep;51(5):478-484. doi: 10.5946/ce.2018.006. Epub 2018 Jun 1.

23.

Long-term rivaroxaban for the treatment of acute venous thromboembolism in patients with active cancer in a prospective multicenter trial.

Yhim HY, Choi WI, Kim SH, Nam SH, Kim KH, Mun YC, Oh D, Hwang HG, Lee KW, Song EK, Kwon YS, Bang SM.

Korean J Intern Med. 2019 Sep;34(5):1125-1135. doi: 10.3904/kjim.2018.097. Epub 2018 May 23.

24.

Transgelin-2 in immunity: Its implication in cell therapy.

Jo S, Kim HR, Mun Y, Jun CD.

J Leukoc Biol. 2018 Nov;104(5):903-910. doi: 10.1002/JLB.MR1117-470R. Epub 2018 May 11. Review.

PMID:
29749649
25.

Synergistic Effect of Molecular-Type Electrocatalysts with Ultrahigh Pore Volume Carbon Microspheres for Lithium-Sulfur Batteries.

Lim WG, Mun Y, Cho A, Jo C, Lee S, Han JW, Lee J.

ACS Nano. 2018 Jun 26;12(6):6013-6022. doi: 10.1021/acsnano.8b02258. Epub 2018 May 14.

PMID:
29746097
26.

Efficacy and Safety of a New 10% Intravenous Immunoglobulin Product in Patients with Primary Immune Thrombocytopenia (ITP).

Hong J, Bang SM, Mun YC, Yhim HY, Lee J, Lim HS, Oh D; Korean GC IVIg Investigators.

J Korean Med Sci. 2018 Apr 24;33(19):e142. doi: 10.3346/jkms.2018.33.e142. eCollection 2018 May 7.

27.

TAGLN2 polymerizes G-actin in a low ionic state but blocks Arp2/3-nucleated actin branching in physiological conditions.

Kim HR, Kwon MS, Lee S, Mun Y, Lee KS, Kim CH, Na BR, Kim BNR, Piragyte I, Lee HS, Jun Y, Jin MS, Hyun YM, Jung HS, Mun JY, Jun CD.

Sci Rep. 2018 Apr 3;8(1):5503. doi: 10.1038/s41598-018-23816-2.

28.

GATA1 Expression in BCR/ABL1-negative Myeloproliferative Neoplasms.

Yang N, Park S, Cho MS, Lee M, Hong KS, Mun YC, Seong CM, Huh HJ, Huh J.

Ann Lab Med. 2018 Jul;38(4):296-305. doi: 10.3343/alm.2018.38.4.296.

29.

Genome-wide genotype-based risk model for survival in core binding factor acute myeloid leukemia patients.

Park S, Choi H, Kim HJ, Ahn JS, Kim HJ, Kim SH, Mun YC, Jung CW, Kim DDH.

Ann Hematol. 2018 Jun;97(6):955-965. doi: 10.1007/s00277-018-3260-6. Epub 2018 Mar 2.

PMID:
29500710
30.

Electrochemical Performance of FeSb₂-P@C Composites as Anode Materials for Lithium-Ion Storage.

Mun YS, Kim D, Kim IT.

J Nanosci Nanotechnol. 2018 Feb 1;18(2):1343-1346. doi: 10.1166/jnn.2018.14920.

PMID:
29448588
31.

Phase 2 Study of an Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma (KMM150).

Jung SH, Lee JJ, Kim JS, Min CK, Kim K, Choi Y, Eom HS, Joo YD, Kim SH, Kwak JY, Kang HJ, Lee JH, Lee HS, Mun YC, Moon JH, Sohn SK, Park SK, Park Y, Shin HJ, Yoon SS; Korean Multiple Myeloma Working Party.

Biol Blood Marrow Transplant. 2018 May;24(5):923-929. doi: 10.1016/j.bbmt.2018.01.004. Epub 2018 Jan 12.

32.

Management of immune thrombocytopenia: Korean experts recommendation in 2017.

Jang JH, Kim JY, Mun YC, Bang SM, Lim YJ, Shin DY, Choi YB, Yhim HY, Lee JW, Kook H; on the behalf of Korean Aplastic Anemia Working Party.

Blood Res. 2017 Dec;52(4):254-263. doi: 10.5045/br.2017.52.4.254. Epub 2017 Dec 26. Review.

33.

Clinicopathological Characteristics of Hyperdiploidy with High-Risk Cytogenetics in Multiple Myeloma.

Yang N, Mun YC, Seong CM, Huh HJ, Huh J.

Ann Lab Med. 2018 Mar;38(2):160-164. doi: 10.3343/alm.2018.38.2.160.

34.

Lymphedema Associated With Primary Amyloidosis: A Case Study.

Park G, Jeong HW, Lee J, Mun YC, Sung SH, Han SJ.

Ann Rehabil Med. 2017 Oct;41(5):887-891. doi: 10.5535/arm.2017.41.5.887. Epub 2017 Oct 31.

35.

Improved prognostic stratification using NCCN- and GELTAMO-international prognostic index in patients with diffuse large B-cell lymphoma.

Hong J, Kim SJ, Chang MH, Kim JA, Kwak JY, Kim JS, Yoon DH, Lee WS, Do YR, Kang HJ, Eom HS, Park Y, Won JH, Mun YC, Kim HJ, Kwon JH, Kong JH, Oh SY, Lee S, Bae SH, Yang DH, Jun HJ, Lee HS, Yun HJ, Lee SI, Kim MK, Yi JH, Lee JH, Kim WS, Suh C.

Oncotarget. 2017 Sep 18;8(54):92171-92182. doi: 10.18632/oncotarget.20988. eCollection 2017 Nov 3.

36.

The role of frontline autologous stem cell transplantation for primary plasma cell leukemia: a retrospective multicenter study (KMM160).

Jung SH, Lee JJ, Kim K, Suh C, Yoon DH, Min CK, Sohn SK, Choi CW, Lee HS, Kim HJ, Shin HJ, Bang SM, Yoon SS, Park SK, Yhim HY, Kim MK, Jo JC, Mun YC, Lee JH, Kim JS; Korean Multiple Myeloma Working Party.

Oncotarget. 2017 Jun 16;8(45):79517-79526. doi: 10.18632/oncotarget.18535. eCollection 2017 Oct 3.

37.

Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma.

Kwong YL, Kim SJ, Tse E, Oh SY, Kwak JY, Eom HS, Do YR, Mun YC, Lee SR, Shin HJ, Suh C, Chuang SS, Lee YS, Lim ST, Izutsu K, Suzuki R, Relander T, d'Amore F, Schmitz N, Jaccard A, Kim WS.

Ann Oncol. 2018 Jan 1;29(1):256-263. doi: 10.1093/annonc/mdx684.

PMID:
29077846
38.

Vemurafenib treatment for patients with locally advanced, unresectable stage IIIC or metastatic melanoma and activating exon 15 BRAF mutations other than V600E.

Hallmeyer S, Gonzalez R, Lawson DH, Cranmer LD, Linette GP, Puzanov I, Taback B, Cowey CL, Ribas A, Daniels GA, Moore T, Gibney GT, Tawbi H, Whitman E, Lee G, Mun Y, Liu S, Hamid O.

Melanoma Res. 2017 Dec;27(6):585-590. doi: 10.1097/CMR.0000000000000398.

PMID:
29076950
39.

Biosignal integrated circuit with simultaneous acquisition of ECG and PPG for wearable healthcare applications.

Kim H, Park Y, Ko Y, Mun Y, Lee S, Ko H.

Technol Health Care. 2018;26(1):3-9. doi: 10.3233/THC-171401.

PMID:
29060948
40.

Orbitofacial dermatofibrosarcoma protuberans with intranasal extension.

Sharudin SN, Tan SW, Mohamad NF, Vasudevan SK, Khairan H, Mun YC, Shanmuganathan J.

Orbit. 2018 Jun;37(3):196-200. doi: 10.1080/01676830.2017.1383474. Epub 2017 Oct 23.

PMID:
29058523
41.

Scopoletin Stimulates Melanogenesis via cAMP/PKA Pathway and Partially p38 Activation.

Kim DS, Cha SB, Park MC, Park SA, Kim HS, Woo WH, Mun YJ.

Biol Pharm Bull. 2017 Dec 1;40(12):2068-2074. doi: 10.1248/bpb.b16-00690. Epub 2017 Sep 22.

42.

Phase III Clinical Trial (RERISE study) Results of Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia.

Kwak JY, Kim SH, Oh SJ, Zang DY, Kim H, Kim JA, Do YR, Kim HJ, Park JS, Choi CW, Lee WS, Mun YC, Kong JH, Chung JS, Shin HJ, Kim DY, Park J, Jung CW, Bunworasate U, Comia NS, Jootar S, Reksodiputro AH, Caguioa PB, Lee SE, Kim DW.

Clin Cancer Res. 2017 Dec 1;23(23):7180-7188. doi: 10.1158/1078-0432.CCR-17-0957. Epub 2017 Sep 22.

43.

Comprehensive evaluation of the revised international staging system in multiple myeloma patients treated with novel agents as a primary therapy.

Cho H, Yoon DH, Lee JB, Kim SY, Moon JH, Do YR, Lee JH, Park Y, Lee HS, Eom HS, Shin HJ, Min CK, Kim JS, Jo JC, Kang HJ, Mun YC, Lee WS, Lee JJ, Suh C, Kim K; and the Korean Multiple Myeloma Working Party.

Am J Hematol. 2017 Dec;92(12):1280-1286. doi: 10.1002/ajh.24891. Epub 2017 Sep 8.

44.

Multicenter Retrospective Analysis of Clinical Characteristics, Treatment Patterns, and Outcomes in Very Elderly Patients with Diffuse Large B-Cell Lymphoma: The Korean Cancer Study Group LY16-01.

Choi JH, Kim TM, Kim HJ, Koh SA, Mun YC, Kang HJ, Jung YH, Shim H, Chong SY, Sun DS, Lee S, Park BB, Kwon JH, Nam SH, Yi JH, Yuh YJ, Jin JY, Han JJ, Kim SH.

Cancer Res Treat. 2018 Apr;50(2):590-598. doi: 10.4143/crt.2017.172. Epub 2017 Jun 9.

45.

A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma.

Kim MK, Kim K, Min CK, Kwak JY, Bae SB, Yoon SS, Lee JJ, Kim KH, Nam SH, Mun YC, Kim HJ, Bae SH, Shin HJ, Lee JH, Park JS, Jeong SH, Lee MH, Kim YS, Lee HS, Park KW, Lee WS, Lee SM, Lee JO, Hyun MS, Jo DY, Lim SN, Lee JH, Cho DY, Do YR, Kim JA, Park SK, Kim JS, Kim SJ, Kim H, Yi HG, Moon JH, Choi CW, Kim SH, Joo YD, Kim HG, Kim BS, Park MR, Song MK, Kim SY.

Oncotarget. 2017 Jun 6;8(23):37605-37618. doi: 10.18632/oncotarget.16790.

46.

A bench-top micro-CT capable of simulating head motions.

Hegazy MAA, Eldib ME, Mun YJ, Cho MH, Cho MH, Lee SY.

Biomed Eng Lett. 2017 Apr 3;7(3):237-244. doi: 10.1007/s13534-017-0023-6. eCollection 2017 Aug.

47.

A Ring Artifact Correction Method: Validation by Micro-CT Imaging with Flat-Panel Detectors and a 2D Photon-Counting Detector.

Eldib ME, Hegazy M, Mun YJ, Cho MH, Cho MH, Lee SY.

Sensors (Basel). 2017 Jan 30;17(2). pii: E269. doi: 10.3390/s17020269.

48.

Ordered Mesoporous Titanium Nitride as a Promising Carbon-Free Cathode for Aprotic Lithium-Oxygen Batteries.

Kim BG, Jo C, Shin J, Mun Y, Lee J, Choi JW.

ACS Nano. 2017 Feb 28;11(2):1736-1746. doi: 10.1021/acsnano.6b07635. Epub 2017 Jan 23.

PMID:
28081367
49.

Femoropopliteal Bypass with Varicose Greater Saphenous Vein.

Mun YS, Cho BS, Jang JH, Lee MS, Kwon OS.

Int J Angiol. 2016 Dec;25(5):e108-e110. doi: 10.1055/s-0035-1546438. Epub 2015 May 25.

50.

Novel deletion mutation of HLA-B*40:02 gene in acquired aplastic anemia.

Jeong TD, Mun YC, Chung HS, Seo D, Im J, Huh J.

HLA. 2017 Jan;89(1):47-51. doi: 10.1111/tan.12943.

PMID:
28025876

Supplemental Content

Support Center